CEL-SCI CORPORATION Financing Cash Flow
CEL-SCI CORPORATION (CVM) reported Financing Cash Flow of $7.65 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $8.67M, a 127.61% increase year-over-year.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$364.46K, a 121.70% decline year-over-year.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$653.77K, a 116.15% decline year-over-year.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $13.84M, a 50.56% increase year-over-year.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was $23.37M, a 19.79% increase from fiscal 2024.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was $19.51M, a 315.64% increase from fiscal 2023.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was $4.69M.
- CEL-SCI CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was -$638.43K, a 101.17% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $8.30M derived: sum of 2 quarters · filed 2026-08-14 | $7.65M 10-Q · filed 2026-08-14 | $21.49M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$364.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$1.02M 10-Q · filed 2026-05-15 | $12.82M derived: sum of 3 quarters · filed 2026-05-15 | $16.63M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$653.77K 10-Q · filed 2026-02-17 | $13.18M derived: sum of 2 quarters · filed 2026-02-17 | $16.99M derived: sum of 3 quarters · filed 2026-08-14 | $18.67M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $17.64M derived: sum of 2 quarters · filed 2026-08-14 | $19.32M derived: sum of 3 quarters · filed 2026-08-14 | $23.37M 10-K · filed 2025-12-29 |
| 2025-06-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $5.49M derived: sum of 2 quarters · filed 2026-08-14 | $9.54M 10-Q · filed 2026-08-14 | $18.73M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $5.73M 10-Q · filed 2026-05-15 | $14.92M derived: sum of 3 quarters · filed 2026-05-15 | $14.60M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $4.05M 10-Q · filed 2026-02-17 | $13.24M derived: sum of 2 quarters · filed 2026-02-17 | $12.92M derived: sum of 3 quarters · filed 2026-02-17 | $19.51M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | $8.87M derived: sum of 2 quarters · filed 2025-12-29 | $15.46M derived: sum of 3 quarters · filed 2025-12-29 | $19.51M 10-K · filed 2025-12-29 |
| 2024-06-30 | -$322.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $6.27M derived: sum of 2 quarters · filed 2025-08-14 | $10.32M 10-Q · filed 2025-08-14 | $14.39M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $10.64M 10-Q · filed 2025-05-14 | $14.71M derived: sum of 3 quarters · filed 2025-05-14 | $15.66M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $4.05M 10-Q · filed 2025-02-14 | $8.11M derived: sum of 2 quarters · filed 2025-02-14 | $9.07M derived: sum of 3 quarters · filed 2025-02-14 | $8.68M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-13 | $5.02M derived: sum of 2 quarters · filed 2025-01-13 | $4.63M derived: sum of 3 quarters · filed 2025-01-13 | $4.69M 10-K · filed 2025-01-13 |
| 2023-06-30 | $951.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $563.21K derived: sum of 2 quarters · filed 2024-08-14 | $628.62K 10-Q · filed 2024-08-14 | $156.87K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$388.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-15 | -$322.94K 10-Q · filed 2024-05-15 | -$794.69K derived: sum of 3 quarters · filed 2024-05-15 | -$1.14M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $65.41K 10-Q · filed 2024-02-14 | -$406.34K derived: sum of 2 quarters · filed 2024-02-14 | -$754.95K derived: sum of 3 quarters · filed 2024-02-14 | -$316.51K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$471.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$820.36K derived: sum of 2 quarters · filed 2023-12-21 | -$381.92K derived: sum of 3 quarters · filed 2023-12-21 | -$638.43K 10-K · filed 2023-12-21 |
| 2022-06-30 | -$348.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-10 | $89.83K derived: sum of 2 quarters · filed 2023-08-10 | -$166.68K 10-Q · filed 2023-08-10 | $148.26K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $438.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $181.93K 10-Q · filed 2023-05-12 | $496.87K derived: sum of 3 quarters · filed 2023-05-12 | $37.22M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$256.51K 10-Q · filed 2023-02-14 | $58.43K derived: sum of 2 quarters · filed 2023-02-14 | $36.78M derived: sum of 3 quarters · filed 2023-02-14 | $40.94M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $314.94K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-27 | $37.04M derived: sum of 2 quarters · filed 2022-12-27 | $41.19M derived: sum of 3 quarters · filed 2022-12-27 | $54.52M 10-K · filed 2022-12-27 |
| 2021-06-30 | $36.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $40.88M derived: sum of 2 quarters · filed 2022-08-12 | $54.21M 10-Q · filed 2022-08-12 | $54.29M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $17.48M 10-Q · filed 2022-05-13 | $17.56M derived: sum of 3 quarters · filed 2022-05-13 | $27.87M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $13.33M 10-Q · filed 2022-02-11 | $13.41M derived: sum of 2 quarters · filed 2022-02-11 | $23.72M derived: sum of 3 quarters · filed 2022-02-11 | $33.21M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | $82.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $10.39M derived: sum of 2 quarters · filed 2021-12-21 | $19.89M derived: sum of 3 quarters · filed 2021-12-21 | $25.04M 10-K · filed 2021-12-21 |
| 2020-06-30 | $10.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $19.80M derived: sum of 2 quarters · filed 2021-08-13 | $24.95M 10-Q · filed 2021-08-13 | $27.85M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $14.64M 10-Q · filed 2021-05-17 | $17.54M derived: sum of 3 quarters · filed 2021-05-17 | $26.21M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.15M 10-Q · filed 2021-02-12 | $8.05M derived: sum of 2 quarters · filed 2021-02-12 | $16.72M derived: sum of 3 quarters · filed 2021-02-12 | $19.34M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-09-30 | $2.90M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | $11.57M derived: sum of 2 quarters · filed 2020-12-31 | $14.19M derived: sum of 3 quarters · filed 2020-12-31 | $14.79M 10-K · filed 2020-12-29 |
| 2019-06-30 | $8.67M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $11.29M derived: sum of 2 quarters · filed 2020-12-31 | $11.90M 10-Q/A · filed 2020-12-31 | $24.16M derived: sum of 4 quarters · filed 2020-12-31 |
| 2019-03-31 | $2.62M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | $3.22M 10-Q/A · filed 2020-12-30 | $15.49M derived: sum of 3 quarters · filed 2020-12-30 | $17.55M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-12-31 | $601.90K 10-Q/A · filed 2020-12-30 | $12.86M derived: sum of 2 quarters · filed 2020-12-30 | $14.93M derived: sum of 3 quarters · filed 2020-12-30 | $19.60M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-09-30 | $12.26M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $14.33M derived: sum of 2 quarters · filed 2019-12-23 | $19.00M derived: sum of 3 quarters · filed 2019-12-23 | $21.39M 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $6.74M derived: sum of 2 quarters · filed 2019-08-14 | $9.13M 10-Q · filed 2019-08-14 | $13.71M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $7.06M 10-Q · filed 2019-05-14 | $11.65M derived: sum of 3 quarters · filed 2019-05-14 | $14.47M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $2.39M 10-Q · filed 2019-02-14 | $6.97M derived: sum of 2 quarters · filed 2019-02-14 | $9.80M derived: sum of 3 quarters · filed 2019-02-14 | $11.94M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $7.41M derived: sum of 2 quarters · filed 2018-12-19 | $9.55M derived: sum of 3 quarters · filed 2018-12-19 | $13.26M 10-K · filed 2018-12-19 |
| 2017-06-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $4.97M derived: sum of 2 quarters · filed 2018-08-14 | $8.68M 10-Q · filed 2018-08-14 | $13.24M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $5.85M 10-Q · filed 2018-05-15 | $10.41M derived: sum of 3 quarters · filed 2018-05-15 | $15.01M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $3.71M 10-Q · filed 2018-02-12 | $8.27M derived: sum of 2 quarters · filed 2018-02-12 | $12.87M derived: sum of 3 quarters · filed 2018-02-12 | $13.47M derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | $4.56M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | $9.16M derived: sum of 2 quarters · filed 2017-12-29 | $9.76M derived: sum of 3 quarters · filed 2017-12-29 | $20.31M 10-K · filed 2017-12-29 |
| 2016-06-30 | $4.60M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $5.20M derived: sum of 2 quarters · filed 2017-12-11 | $15.75M 10-Q/A · filed 2017-12-11 | $15.61M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $601.46K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $11.15M 10-Q/A · filed 2017-12-11 | $11.02M derived: sum of 3 quarters · filed 2017-12-11 | $25.89M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $10.55M 10-Q/A · filed 2017-12-11 | $10.42M derived: sum of 2 quarters · filed 2017-12-11 | $25.29M derived: sum of 3 quarters · filed 2017-12-11 | $25.28M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | -$132.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $14.74M derived: sum of 2 quarters · filed 2017-12-11 | $14.74M derived: sum of 3 quarters · filed 2017-12-11 | $21.14M 10-K/A · filed 2017-12-11 |
| 2015-06-30 | $14.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $14.87M derived: sum of 2 quarters · filed 2016-08-09 | $21.27M 10-Q · filed 2016-08-09 | $21.27M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-03-31 | -$2.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $6.40M 10-Q · filed 2016-05-10 | $6.40M derived: sum of 3 quarters · filed 2017-12-11 | $16.15M derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-12-31 | $6.40M 10-Q · filed 2016-02-09 | $6.40M derived: sum of 2 quarters · filed 2017-12-11 | $16.15M derived: sum of 3 quarters · filed 2017-12-11 | $18.57M derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-09-30 | -$2.03K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $9.75M derived: sum of 2 quarters · filed 2017-12-11 | $12.16M derived: sum of 3 quarters · filed 2017-12-11 | $31.54M 10-K/A · filed 2017-12-11 |
| 2014-06-30 | $9.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $12.16M derived: sum of 2 quarters · filed 2015-08-07 | $31.54M 10-Q · filed 2015-08-07 | $31.52M derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $21.79M 10-Q · filed 2015-05-08 | $21.77M derived: sum of 3 quarters · filed 2015-12-11 | $21.77M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $19.38M 10-Q · filed 2015-02-06 | $19.36M derived: sum of 2 quarters · filed 2015-12-11 | $19.35M derived: sum of 3 quarters · filed 2015-12-11 | $19.35M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | -$21.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$22.77K derived: sum of 2 quarters · filed 2015-12-11 | -$24.44K derived: sum of 3 quarters · filed 2015-12-11 | $9.78M 10-K · filed 2015-12-11 |
| 2013-06-30 | -$1.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | -$3.41K derived: sum of 2 quarters · filed 2014-08-08 | $9.80M 10-Q · filed 2014-08-08 | $9.80M derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-03-31 | -$1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $9.80M 10-Q · filed 2014-05-12 | $9.80M derived: sum of 3 quarters · filed 2014-12-23 | $14.93M derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-12-31 | $9.81M 10-Q · filed 2014-02-10 | $9.81M derived: sum of 2 quarters · filed 2014-12-23 | $14.93M derived: sum of 3 quarters · filed 2014-12-23 | $19.98M derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $5.12M derived: sum of 2 quarters · filed 2014-12-23 | $10.17M derived: sum of 3 quarters · filed 2014-12-23 | $12.00M 10-K · filed 2014-12-23 |
| 2012-06-30 | $5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | $10.17M derived: sum of 2 quarters · filed 2013-08-09 | $12.00M 10-Q · filed 2013-08-09 | $10.64M derived: sum of 4 quarters · filed 2013-12-27 |
| 2012-03-31 | $5.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | $6.88M 10-Q · filed 2013-05-10 | $5.52M derived: sum of 3 quarters · filed 2013-12-27 | $5.61M derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-12-31 | $1.83M 10-Q · filed 2013-02-08 | $464.29K derived: sum of 2 quarters · filed 2013-12-27 | $559.92K derived: sum of 3 quarters · filed 2013-12-27 | $1.65M derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-09-30 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$1.27M derived: sum of 2 quarters · filed 2013-12-27 | -$183.92K derived: sum of 3 quarters · filed 2013-12-27 | $565.87K 10-K · filed 2013-12-27 |
| 2011-06-30 | $95.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | $1.18M derived: sum of 2 quarters · filed 2012-08-09 | $1.93M 10-Q · filed 2012-08-09 | $1.93M derived: sum of 4 quarters · filed 2012-12-14 |
| 2011-03-31 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | $1.84M 10-Q · filed 2012-05-10 | $1.84M derived: sum of 3 quarters · filed 2012-12-14 | |
| 2010-12-31 | $749.79K 10-Q · filed 2012-02-09 | $749.79K derived: sum of 2 quarters · filed 2012-12-14 | ||
| 2010-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | $6.31M 10-K · filed 2012-12-14 | ||
| 2010-06-30 | $6.31M 10-Q · filed 2011-08-09 | |||
| 2009-09-30 | $39.00M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |